CAS: 179045-86-4 - Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 γ1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer
Formel:Unspecified
- Synonyme:
- Basiliximab
- CHI 621
- Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 γ1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer
- Simulect
- Immunoglobulin G 1 (human-mouse monoclonal CHI621 heavy chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal CHI621 light chain, dimer
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Basiliximab REF: TM-T73698CAS: 179045-86-4 | SDS-PAGE:94.1%;SEC-HPLC:95.3% | 398,00 €~4.592,00 € | Di 15 Okt 24 |
 | Basiliximab REF: 3D-CLA1120CAS: 179045-86-4 | - - - | Nachfragen | Mi 23 Okt 24 |
Basiliximab
CAS:179045-86-4
Basiliximab: chimeric IgG1 antibody inhibiting interleukin-2 receptor, used for kidney transplant immunosuppression.
Reinheit:
SDS-PAGE:94.1%;SEC-HPLC:95.3%
Farbe und Form:
Solid
Ref: TM-T73698
| 1mg | 398,00 € | ||
| 5mg | 1.096,00 € | ||
| 10mg | 1.742,00 € | ||
| 25mg | 2.580,00 € | ||
| 50mg | 3.464,00 € | ||
| 100mg | 4.592,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 15. Oktober 2024
Basiliximab
CAS:179045-86-4
Chimeric mouse-human monoclonal antibody targeting CD25; used to prevent organ rejection
Ref: 3D-CLA1120
| Unbestimmte Größe | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 23. Oktober 2024
